Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CENTENE CORPORATION

(CNC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Centene: Q2 Earnings Snapshot

07/27/2021 | 06:17am EDT

ST LOUIS (AP) _ Centene Corp. (CNC) on Tuesday reported a second-quarter loss of $535 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the St. Louis-based company said it had a loss of 92 cents. Earnings, adjusted for one-time gains and costs, came to $1.25 per share.

The results missed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $1.41 per share.

The healthcare company posted revenue of $31.03 billion in the period, exceeding Street forecasts. Five analysts surveyed by Zacks expected $30.13 billion.

Centene expects full-year earnings in the range of $5.05 to $5.35 per share, with revenue in the range of $12.33 billion to $12.53 billion.

Centene shares have risen 21% since the beginning of the year. The stock has climbed nearly 8% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CNC at https://www.zacks.com/ap/CNC

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about CENTENE CORPORATION
09/20CENTENE : Donates Connected Devices to Foster Youth
PR
09/15WALL STREET STOCK EXCHANGE : Yes, the global economic recovery is slowing
09/15ANALYST RECOMMENDATIONS : Chevron, Centene, Darktrace, Flutter, Malibu Boats...
09/14CENTENE : Mizuho Securities Adjusts Centene PT to $75 From $67, Maintains Neutral Rating
MT
09/14CENTENE : Morgan Stanley Adjusts Centene's Price Target to $79 from $88, Keeps Overweight ..
MT
09/14CENTENE : Credit Suisse Adjusts Price Target for Centene to $70 From $73.50, Maintains Neu..
MT
09/14REMINDER : Centene Corporation's 2021 Third Quarter Financial Results Conference Call
PR
09/08CENTENE : Bernstein Adjusts Centene's Price Target to $92 from $102, Keeps Outperform Rati..
MT
09/08CENTENE : Mizuho Securities Adjusts Centene PT to $67 From $75, Maintains Neutral Rating
MT
09/07RITE AID : Subsidiary Elixir Names Lance Neill Chief Operating Officer
MT
More news
Analyst Recommendations on CENTENE CORPORATION
More recommendations
Financials (USD)
Sales 2021 125 B - -
Net income 2021 1 191 M - -
Net Debt 2021 9 280 M - -
P/E ratio 2021 31,4x
Yield 2021 -
Capitalization 36 784 M 36 784 M -
EV / Sales 2021 0,37x
EV / Sales 2022 0,36x
Nbr of Employees 71 300
Free-Float 96,0%
Chart CENTENE CORPORATION
Duration : Period :
Centene Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CENTENE CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 19
Last Close Price 63,09 $
Average target price 84,58 $
Spread / Average Target 34,1%
EPS Revisions
Managers and Directors
Michael F. Neidorff Chairman & Chief Executive Officer
Brent Davis Layton President & Chief Operating Officer
Andrew Lynn Asher Chief Financial Officer & Executive Vice President
Mary V. Mason Chief Medial Officer & Senior Vice President
Ken Yamaguchi Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
CENTENE CORPORATION5.10%36 784
UNITEDHEALTH GROUP17.69%389 142
ANTHEM, INC.17.38%91 894
CIGNA CORPORATION-2.71%68 882
HUMANA INC.-1.50%51 930
MOLINA HEALTHCARE, INC.31.34%16 200